CLINICAL TRIALS PROFILE FOR SYNDROS
✉ Email this page to a colleague
All Clinical Trials for SYNDROS
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT03661892 ↗ | Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets | Completed | University of Arizona | Early Phase 1 | 2018-12-19 | In patients with cancer induced bone pain, addition of Syndros will improve pain relief and decrease opioid requirement. |
| NCT04346407 ↗ | Dronabinol for Post-operative Pain After Lumbar Fusion | Enrolling by invitation | Jeffrey L Gum MD | Phase 4 | 2020-09-01 | Impact of 2.5mg of oral Dronabinol daily versus placebo on post-operative opioid consumption on patients aged 18 to 65 years old undergoing 1 to 3 level posterolateral fusion |
| NCT06034314 ↗ | Oral Dronabinol-HIV | Recruiting | National Institute on Drug Abuse (NIDA) | Phase 1 | 2023-09-21 | The purpose of this study is to define the mechanisms of cannabis on the genome of people with HIV who use cannabis. The investigator aims to better understand the effect of Dronabinol on immune and inflammatory functions, and whether these changes are HIV-status dependent. This research may better inform public health policy regarding cannabis use. Depending on the results, additional studies may also build upon this research to develop more effective and specific treatments for cannabis use associated disorders. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SYNDROS
Condition Name
Clinical Trial Locations for SYNDROS
Trials by Country
Clinical Trial Progress for SYNDROS
Clinical Trial Phase
Clinical Trial Sponsors for SYNDROS
Sponsor Name
